PubMed:18161024
Annnotations
GlyCosmos6-Glycan-Motif-Image
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 802-813 | Glycan_Motif | denotes | chondroitin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G43702JT |
PMID_GLOBAL
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 54-67 | DiseaseOrPhenotypicFeature | denotes | pre-eclampsia | 0005081 |
| T2 | 144-157 | DiseaseOrPhenotypicFeature | denotes | pre-eclampsia | 0005081 |
| T3 | 269-282 | DiseaseOrPhenotypicFeature | denotes | pre-eclampsia | 0005081 |
| T4 | 467-480 | DiseaseOrPhenotypicFeature | denotes | pre-eclampsia | 0005081 |
| T5 | 562-575 | DiseaseOrPhenotypicFeature | denotes | pre-eclampsia | 0005081 |
| T6 | 1016-1029 | DiseaseOrPhenotypicFeature | denotes | pre-eclampsia | 0005081 |
| T7 | 1299-1312 | DiseaseOrPhenotypicFeature | denotes | pre-eclampsia | 0005081 |
| T8 | 1351-1364 | DiseaseOrPhenotypicFeature | denotes | pre-eclampsia | 0005081 |
| T9 | 1526-1539 | DiseaseOrPhenotypicFeature | denotes | pre-eclampsia | 0005081 |
GlyCosmos6-Glycan-Motif-Structure
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 802-813 | https://glytoucan.org/Structures/Glycans/G43702JT | denotes | chondroitin |
Glycosmos6-MAT
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 9-17 | http://purl.obolibrary.org/obo/MAT_0000279 | denotes | placenta |
| T2 | 257-265 | http://purl.obolibrary.org/obo/MAT_0000279 | denotes | placenta |
| T3 | 494-502 | http://purl.obolibrary.org/obo/MAT_0000279 | denotes | placenta |
| T4 | 576-585 | http://purl.obolibrary.org/obo/MAT_0000279 | denotes | placentas |
| T5 | 1042-1050 | http://purl.obolibrary.org/obo/MAT_0000279 | denotes | placenta |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-68 | Sentence | denotes | Is human placenta proteoglycan remodeling involved in pre-eclampsia? |
| TextSentencer_T2 | 69-158 | Sentence | denotes | Impaired placento-fetal communication is a coherent symptom of exaggerated pre-eclampsia. |
| TextSentencer_T3 | 159-300 | Sentence | denotes | The impact of the cellular expression of different glycosaminoglycans (GAGs) in this event on the placenta in pre-eclampsia is still obscure. |
| TextSentencer_T4 | 301-503 | Sentence | denotes | This is the first study aimed at discovering the relationship between structural alterations of different sulfated GAGs at the molecular level and the development of pre-eclampsia in inflicted placenta. |
| TextSentencer_T5 | 504-586 | Sentence | denotes | Sulfated GAGs were isolated and purified from control and pre-eclampsia placentas. |
| TextSentencer_T6 | 587-666 | Sentence | denotes | The amount and the molecular weight of GAG in each tissue sample were measured. |
| TextSentencer_T7 | 667-769 | Sentence | denotes | The polydispersity of the recovered GAG samples were determined by polyacrylamide gel electrophoresis. |
| TextSentencer_T8 | 770-975 | Sentence | denotes | The disaccharide composition of chondroitin sulfate, dermatan sulfate and heparan sulfate were deduced by chondroitinase and heparinase depolymerization followed by liquid chromatography-mass spectrometry. |
| TextSentencer_T9 | 976-1176 | Sentence | denotes | The in vivo sulfo-modulation of GAGs in pre-eclampsia and control placenta were examined using RT-PCR to determine the transcription levels of different sulfotransferases involved in GAG biosynthesis. |
| TextSentencer_T10 | 1177-1313 | Sentence | denotes | Marked differences in GAG sulfation patterns and mRNA level of encoding selected GAG O-sulfotransferases were observed in pre-eclampsia. |
| TextSentencer_T11 | 1314-1540 | Sentence | denotes | These data suggest a linkage between pre-eclampsia and the observed alterations in placental GAGs and could provide new insights about the modulating role of GAGs in the development and the severity of placental pre-eclampsia. |
| TextSentencer_T1 | 0-68 | Sentence | denotes | Is human placenta proteoglycan remodeling involved in pre-eclampsia? |
| TextSentencer_T2 | 69-158 | Sentence | denotes | Impaired placento-fetal communication is a coherent symptom of exaggerated pre-eclampsia. |
| TextSentencer_T3 | 159-300 | Sentence | denotes | The impact of the cellular expression of different glycosaminoglycans (GAGs) in this event on the placenta in pre-eclampsia is still obscure. |
| TextSentencer_T4 | 301-503 | Sentence | denotes | This is the first study aimed at discovering the relationship between structural alterations of different sulfated GAGs at the molecular level and the development of pre-eclampsia in inflicted placenta. |
| TextSentencer_T5 | 504-586 | Sentence | denotes | Sulfated GAGs were isolated and purified from control and pre-eclampsia placentas. |
| TextSentencer_T6 | 587-666 | Sentence | denotes | The amount and the molecular weight of GAG in each tissue sample were measured. |
| TextSentencer_T7 | 667-769 | Sentence | denotes | The polydispersity of the recovered GAG samples were determined by polyacrylamide gel electrophoresis. |
| TextSentencer_T8 | 770-975 | Sentence | denotes | The disaccharide composition of chondroitin sulfate, dermatan sulfate and heparan sulfate were deduced by chondroitinase and heparinase depolymerization followed by liquid chromatography-mass spectrometry. |
| TextSentencer_T9 | 976-1176 | Sentence | denotes | The in vivo sulfo-modulation of GAGs in pre-eclampsia and control placenta were examined using RT-PCR to determine the transcription levels of different sulfotransferases involved in GAG biosynthesis. |
| TextSentencer_T10 | 1177-1313 | Sentence | denotes | Marked differences in GAG sulfation patterns and mRNA level of encoding selected GAG O-sulfotransferases were observed in pre-eclampsia. |
| TextSentencer_T11 | 1314-1540 | Sentence | denotes | These data suggest a linkage between pre-eclampsia and the observed alterations in placental GAGs and could provide new insights about the modulating role of GAGs in the development and the severity of placental pre-eclampsia. |
| T1 | 0-68 | Sentence | denotes | Is human placenta proteoglycan remodeling involved in pre-eclampsia? |
| T2 | 69-158 | Sentence | denotes | Impaired placento-fetal communication is a coherent symptom of exaggerated pre-eclampsia. |
| T3 | 159-300 | Sentence | denotes | The impact of the cellular expression of different glycosaminoglycans (GAGs) in this event on the placenta in pre-eclampsia is still obscure. |
| T4 | 301-503 | Sentence | denotes | This is the first study aimed at discovering the relationship between structural alterations of different sulfated GAGs at the molecular level and the development of pre-eclampsia in inflicted placenta. |
| T5 | 504-586 | Sentence | denotes | Sulfated GAGs were isolated and purified from control and pre-eclampsia placentas. |
| T6 | 587-666 | Sentence | denotes | The amount and the molecular weight of GAG in each tissue sample were measured. |
| T7 | 667-769 | Sentence | denotes | The polydispersity of the recovered GAG samples were determined by polyacrylamide gel electrophoresis. |
| T8 | 770-975 | Sentence | denotes | The disaccharide composition of chondroitin sulfate, dermatan sulfate and heparan sulfate were deduced by chondroitinase and heparinase depolymerization followed by liquid chromatography-mass spectrometry. |
| T9 | 976-1176 | Sentence | denotes | The in vivo sulfo-modulation of GAGs in pre-eclampsia and control placenta were examined using RT-PCR to determine the transcription levels of different sulfotransferases involved in GAG biosynthesis. |
| T10 | 1177-1313 | Sentence | denotes | Marked differences in GAG sulfation patterns and mRNA level of encoding selected GAG O-sulfotransferases were observed in pre-eclampsia. |
| T11 | 1314-1540 | Sentence | denotes | These data suggest a linkage between pre-eclampsia and the observed alterations in placental GAGs and could provide new insights about the modulating role of GAGs in the development and the severity of placental pre-eclampsia. |
Glycosmos6-GlycoEpitope
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 802-813 | http://www.glycoepitope.jp/epitopes/EP0081 | denotes | chondroitin |
| T2 | 844-859 | http://www.glycoepitope.jp/epitopes/EP0086 | denotes | heparan sulfate |
Preeclampsia
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-Preeclampsia-B_T1 | 54-67 | ORPHA:275555 | denotes | pre-eclampsia |
| PD-Preeclampsia-B_T2 | 144-157 | ORPHA:275555 | denotes | pre-eclampsia |
| PD-Preeclampsia-B_T3 | 269-282 | ORPHA:275555 | denotes | pre-eclampsia |
| PD-Preeclampsia-B_T4 | 467-480 | ORPHA:275555 | denotes | pre-eclampsia |
| PD-Preeclampsia-B_T5 | 562-575 | ORPHA:275555 | denotes | pre-eclampsia |
| PD-Preeclampsia-B_T6 | 1016-1029 | ORPHA:275555 | denotes | pre-eclampsia |
| PD-Preeclampsia-B_T7 | 1299-1312 | ORPHA:275555 | denotes | pre-eclampsia |
| PD-Preeclampsia-B_T8 | 1351-1364 | ORPHA:275555 | denotes | pre-eclampsia |
| PD-Preeclampsia-B_T9 | 1526-1539 | ORPHA:275555 | denotes | pre-eclampsia |
Preeclampsia-compare
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-Preeclampsia-B_T1 | 54-67 | ORPHA:275555 | denotes | pre-eclampsia |
| PD-Preeclampsia-B_T2 | 144-157 | ORPHA:275555 | denotes | pre-eclampsia |
| PD-Preeclampsia-B_T3 | 269-282 | ORPHA:275555 | denotes | pre-eclampsia |
| PD-Preeclampsia-B_T4 | 467-480 | ORPHA:275555 | denotes | pre-eclampsia |
| PD-Preeclampsia-B_T5 | 562-575 | ORPHA:275555 | denotes | pre-eclampsia |
| PD-Preeclampsia-B_T6 | 1016-1029 | ORPHA:275555 | denotes | pre-eclampsia |
| PD-Preeclampsia-B_T7 | 1299-1312 | ORPHA:275555 | denotes | pre-eclampsia |
| PD-Preeclampsia-B_T8 | 1351-1364 | ORPHA:275555 | denotes | pre-eclampsia |
| PD-Preeclampsia-B_T9 | 1526-1539 | ORPHA:275555 | denotes | pre-eclampsia |
UBERON-AE
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-UBERON-AE-B_T1 | 9-17 | http://purl.obolibrary.org/obo/UBERON_0001987 | denotes | placenta |
| PD-UBERON-AE-B_T2 | 257-265 | http://purl.obolibrary.org/obo/UBERON_0001987 | denotes | placenta |
| PD-UBERON-AE-B_T3 | 494-502 | http://purl.obolibrary.org/obo/UBERON_0001987 | denotes | placenta |
| PD-UBERON-AE-B_T4 | 1042-1050 | http://purl.obolibrary.org/obo/UBERON_0001987 | denotes | placenta |
| PD-UBERON-AE-B_T5 | 638-644 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissue |
performance-test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-UBERON-AE-B_T1 | 638-644 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissue |
| PD-UBERON-AE-B_T2 | 9-17 | http://purl.obolibrary.org/obo/UBERON_0001987 | denotes | placenta |
| PD-UBERON-AE-B_T3 | 257-265 | http://purl.obolibrary.org/obo/UBERON_0001987 | denotes | placenta |
| PD-UBERON-AE-B_T4 | 494-502 | http://purl.obolibrary.org/obo/UBERON_0001987 | denotes | placenta |
| PD-UBERON-AE-B_T5 | 576-585 | http://purl.obolibrary.org/obo/UBERON_0001987 | denotes | placentas |
| PD-UBERON-AE-B_T6 | 1042-1050 | http://purl.obolibrary.org/obo/UBERON_0001987 | denotes | placenta |
| PD-UBERON-AE-B_T7 | 1397-1406 | http://purl.obolibrary.org/obo/UBERON_0001987 | denotes | placental |
| PD-UBERON-AE-B_T8 | 1516-1525 | http://purl.obolibrary.org/obo/UBERON_0001987 | denotes | placental |
GlyCosmos15-Glycan
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 802-813 | Glycan | denotes | chondroitin | https://api.glycosmos.org/wurcs2image/latest/png/binary/G43702JT |
| T3 | 844-859 | Glycan | denotes | heparan sulfate | https://api.glycosmos.org/wurcs2image/latest/png/binary/G17927IW |
mondo_disease
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 54-67 | Disease | denotes | pre-eclampsia | http://purl.obolibrary.org/obo/MONDO_0005081 |
| T2 | 144-157 | Disease | denotes | pre-eclampsia | http://purl.obolibrary.org/obo/MONDO_0005081 |
| T3 | 269-282 | Disease | denotes | pre-eclampsia | http://purl.obolibrary.org/obo/MONDO_0005081 |
| T4 | 467-480 | Disease | denotes | pre-eclampsia | http://purl.obolibrary.org/obo/MONDO_0005081 |
| T5 | 562-575 | Disease | denotes | pre-eclampsia | http://purl.obolibrary.org/obo/MONDO_0005081 |
| T6 | 1016-1029 | Disease | denotes | pre-eclampsia | http://purl.obolibrary.org/obo/MONDO_0005081 |
| T7 | 1299-1312 | Disease | denotes | pre-eclampsia | http://purl.obolibrary.org/obo/MONDO_0005081 |
| T8 | 1351-1364 | Disease | denotes | pre-eclampsia | http://purl.obolibrary.org/obo/MONDO_0005081 |
| T9 | 1526-1539 | Disease | denotes | pre-eclampsia | http://purl.obolibrary.org/obo/MONDO_0005081 |
Glycan-GlyCosmos
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 802-813 | Glycan | denotes | chondroitin | https://api.glycosmos.org/wurcs2image/latest/png/binary/G43702JT |
| T2 | 844-859 | Glycan | denotes | heparan sulfate | https://api.glycosmos.org/wurcs2image/latest/png/binary/G17927IW |
GlyCosmos-GlycoEpitope
| Id | Subject | Object | Predicate | Lexical cue | glycoepitope_id |
|---|---|---|---|---|---|
| T1 | 802-813 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | chondroitin | http://www.glycoepitope.jp/epitopes/EP0081 |
| T2 | 844-859 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | heparan sulfate | http://www.glycoepitope.jp/epitopes/EP0086 |
GlyCosmos15-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 54-67 | Disease | denotes | pre-eclampsia | MONDO:0005081 |
| T2 | 144-157 | Disease | denotes | pre-eclampsia | MONDO:0005081 |
| T3 | 269-282 | Disease | denotes | pre-eclampsia | MONDO:0005081 |
| T4 | 467-480 | Disease | denotes | pre-eclampsia | MONDO:0005081 |
| T5 | 562-575 | Disease | denotes | pre-eclampsia | MONDO:0005081 |
| T6 | 1016-1029 | Disease | denotes | pre-eclampsia | MONDO:0005081 |
| T7 | 1299-1312 | Disease | denotes | pre-eclampsia | MONDO:0005081 |
| T8 | 1351-1364 | Disease | denotes | pre-eclampsia | MONDO:0005081 |
| T9 | 1526-1539 | Disease | denotes | pre-eclampsia | MONDO:0005081 |
GlyCosmos15-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 9-17 | Body_part | denotes | placenta | http://purl.obolibrary.org/obo/UBERON_0001987 |
| T2 | 257-265 | Body_part | denotes | placenta | http://purl.obolibrary.org/obo/UBERON_0001987 |
| T3 | 494-502 | Body_part | denotes | placenta | http://purl.obolibrary.org/obo/UBERON_0001987 |
| T4 | 576-585 | Body_part | denotes | placentas | http://purl.obolibrary.org/obo/UBERON_0001987 |
| T5 | 638-644 | Body_part | denotes | tissue | http://purl.obolibrary.org/obo/UBERON_0000479 |
| T6 | 1042-1050 | Body_part | denotes | placenta | http://purl.obolibrary.org/obo/UBERON_0001987 |
GlyCosmos15-Taxon
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 3-8 | Organism | denotes | human | 9606 |
GlyCosmos15-Sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-68 | Sentence | denotes | Is human placenta proteoglycan remodeling involved in pre-eclampsia? |
| T2 | 69-158 | Sentence | denotes | Impaired placento-fetal communication is a coherent symptom of exaggerated pre-eclampsia. |
| T3 | 159-300 | Sentence | denotes | The impact of the cellular expression of different glycosaminoglycans (GAGs) in this event on the placenta in pre-eclampsia is still obscure. |
| T4 | 301-503 | Sentence | denotes | This is the first study aimed at discovering the relationship between structural alterations of different sulfated GAGs at the molecular level and the development of pre-eclampsia in inflicted placenta. |
| T5 | 504-586 | Sentence | denotes | Sulfated GAGs were isolated and purified from control and pre-eclampsia placentas. |
| T6 | 587-666 | Sentence | denotes | The amount and the molecular weight of GAG in each tissue sample were measured. |
| T7 | 667-769 | Sentence | denotes | The polydispersity of the recovered GAG samples were determined by polyacrylamide gel electrophoresis. |
| T8 | 770-975 | Sentence | denotes | The disaccharide composition of chondroitin sulfate, dermatan sulfate and heparan sulfate were deduced by chondroitinase and heparinase depolymerization followed by liquid chromatography-mass spectrometry. |
| T9 | 976-1176 | Sentence | denotes | The in vivo sulfo-modulation of GAGs in pre-eclampsia and control placenta were examined using RT-PCR to determine the transcription levels of different sulfotransferases involved in GAG biosynthesis. |
| T10 | 1177-1313 | Sentence | denotes | Marked differences in GAG sulfation patterns and mRNA level of encoding selected GAG O-sulfotransferases were observed in pre-eclampsia. |
| T11 | 1314-1540 | Sentence | denotes | These data suggest a linkage between pre-eclampsia and the observed alterations in placental GAGs and could provide new insights about the modulating role of GAGs in the development and the severity of placental pre-eclampsia. |
GlyCosmos15-GlycoEpitope
| Id | Subject | Object | Predicate | Lexical cue | glycoepitope_id |
|---|---|---|---|---|---|
| T1 | 802-813 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | chondroitin | http://www.glycoepitope.jp/epitopes/EP0081 |
| T2 | 844-859 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | heparan sulfate | http://www.glycoepitope.jp/epitopes/EP0086 |
GlyCosmos15-FMA
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 9-17 | Body_part | denotes | placenta | FMA:0329329|FMA:63934 |
| T3 | 257-265 | Body_part | denotes | placenta | FMA:0329329|FMA:63934 |
| T5 | 494-502 | Body_part | denotes | placenta | FMA:0329329|FMA:63934 |
| T7 | 576-585 | Body_part | denotes | placentas | FMA:0329329|FMA:63934 |
| T9 | 638-644 | Body_part | denotes | tissue | FMA:9637 |
| T10 | 1042-1050 | Body_part | denotes | placenta | FMA:0329329|FMA:63934 |
GlyCosmos15-MAT
| Id | Subject | Object | Predicate | Lexical cue | mat_id |
|---|---|---|---|---|---|
| T1 | 9-17 | Body_part | denotes | placenta | http://purl.obolibrary.org/obo/MAT_0000279 |
| T2 | 257-265 | Body_part | denotes | placenta | http://purl.obolibrary.org/obo/MAT_0000279 |
| T3 | 494-502 | Body_part | denotes | placenta | http://purl.obolibrary.org/obo/MAT_0000279 |
| T4 | 576-585 | Body_part | denotes | placentas | http://purl.obolibrary.org/obo/MAT_0000279 |
| T5 | 1042-1050 | Body_part | denotes | placenta | http://purl.obolibrary.org/obo/MAT_0000279 |
NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 3-8 | OrganismTaxon | denotes | human | 9606 |
Anatomy-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 9-17 | Body_part | denotes | placenta | http://purl.obolibrary.org/obo/UBERON_0001987 |
| T2 | 257-265 | Body_part | denotes | placenta | http://purl.obolibrary.org/obo/UBERON_0001987 |
| T3 | 494-502 | Body_part | denotes | placenta | http://purl.obolibrary.org/obo/UBERON_0001987 |
| T4 | 576-585 | Body_part | denotes | placentas | http://purl.obolibrary.org/obo/UBERON_0001987 |
| T5 | 638-644 | Body_part | denotes | tissue | http://purl.obolibrary.org/obo/UBERON_0000479 |
| T6 | 1042-1050 | Body_part | denotes | placenta | http://purl.obolibrary.org/obo/UBERON_0001987 |
Anatomy-MAT
| Id | Subject | Object | Predicate | Lexical cue | mat_id |
|---|---|---|---|---|---|
| T1 | 9-17 | Body_part | denotes | placenta | http://purl.obolibrary.org/obo/MAT_0000279 |
| T2 | 257-265 | Body_part | denotes | placenta | http://purl.obolibrary.org/obo/MAT_0000279 |
| T3 | 494-502 | Body_part | denotes | placenta | http://purl.obolibrary.org/obo/MAT_0000279 |
| T4 | 576-585 | Body_part | denotes | placentas | http://purl.obolibrary.org/obo/MAT_0000279 |
| T5 | 1042-1050 | Body_part | denotes | placenta | http://purl.obolibrary.org/obo/MAT_0000279 |